Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 6;14(1):434.
doi: 10.1038/s41467-023-35898-2.

Barrier-to-autointegration factor 1 promotes gammaherpesvirus reactivation from latency

Affiliations

Barrier-to-autointegration factor 1 promotes gammaherpesvirus reactivation from latency

Grant Broussard et al. Nat Commun. .

Abstract

Gammaherpesviruses, including Kaposi sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV), are DNA viruses that are globally associated with human cancers and establish lifelong latency in the human population. Detection of gammaherpesviral infection by the cGAS-STING innate immune DNA-sensing pathway is critical for suppressing viral reactivation from latency, a process that promotes viral pathogenesis and transmission. We report that barrier-to-autointegration factor 1 (BAF)-mediated suppression of the cGAS-STING signaling pathway is necessary for reactivation of KSHV and EBV. We demonstrate a role for BAF in destabilizing cGAS expression and show that inhibiting BAF expression in latently infected, reactivating, or uninfected cells leads to increased type I interferon-mediated antiviral responses and decreased viral replication. Furthermore, BAF overexpression resulted in decreased cGAS expression at the protein level. These results establish BAF as a key regulator of the lifecycle of gammaherpesviruses and a potential target for treating viral infections and malignancies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. BAF is required for optimal KSHV reactivation from latency.
iSLK.219 cells were transfected with non-targeting control (NTC) siRNA or BANF1 targeting siRNA 48 h prior to the addition of 25 ng/mL doxycycline. TREx-BCBL1-RTA cells were transduced with lentiviral shRNA for 72 h prior to the addition of 1000 ng/mL doxycycline. A Fluorescent microscopy imaging of iSLK.219 cells for RFP and GFP signal at 72 h post-doxycycline treatment. B The fluorescence was quantified by plate reader. C Cells were harvested for RNA at 72 h (iSLK.219) or 96 h (TREx-BCBL1-RTA) post-doxycycline treatment and subsequent RT-qPCR was performed to quantify expression of viral mRNA transcripts. D iSLK.219 cDNA was prepared from cells harvested at 0 h and 72 h post-doxycycline treatment. Global KSHV gene expression profiling was performed. Data shown are the Z-score of the fold change (2-ΔΔCt) over the geometric mean expression of three housekeeping genes averaged over two independent biological replicates. The heatmap was prepared using Partek Flow. E Cell lysates were prepared at 72 h (iSLK.219) or 96 h (TREx-BCBL1-RTA) post-doxycycline treatment and analyzed by western blotting with the indicated antibodies. F Cells were harvested and RNA isolated at 48 h post-siRNA transfection and RT-qPCR was subsequently performed to quantify BANF1 mRNA transcripts. G Cell lysates were prepared at 48 h post-siRNA transfection or 72 h post-shRNA transduction and analyzed by western blotting with the indicated antibody. P values are the result of two-tailed Student’s T tests unless otherwise specified. Error bars indicate the standard error of the mean of three independent biological replicates. Source data are provided as a source data file.
Fig. 2
Fig. 2. BAF antagonizes the cGAS-STING response to KSHV reactivation.
iSLK.219 cells were transfected with NTC siRNA or BANF1 targeting siRNA for 48 h prior to the addition of 25 ng/mL doxycycline. TREx-BCBL1-RTA cells were transduced with lentiviral shRNA for 72 h prior to the addition of 1000 ng/mL doxycycline. A iSLK.219 cell lysates were collected at 72 h post-doxycycline treatment and analyzed by 2’3’-cGAMP ELISA. B iSLK.219 cell lysates were collected at 48 h post-doxycycline treatment and analyzed by western blotting with the indicated antibodies. C iSLK.219 culture supernatant was harvested at 72 h post-doxycycline treatment and analyzed by IFNβ ELISA. D Cells were harvested for RNA at 48 h (iSLK.219) or 96 h (TREx-BCBL1-RTA) post-doxycycline treatment and RT-qPCR was subsequently performed to determine ISG mRNA expression levels. E iSLK.219 cDNA as prepared in (D) was analyzed by Human Type I Interferon Response RT2 Profiler PCR Array (Qiagen, GeneGlobe ID: PAHS-016Z). Data shown are the Z-score of the fold change (2-ΔΔCt) over the geometric mean expression of four housekeeping genes averaged over two independent biological replicates. The heatmap was prepared using Partek Flow. F Culture supernatants were harvested at either 72 h (iSLK.219) or 96 h (TREx-BCBL1-RTA) post-doxycycline treatment and DNase treated prior to DNA extraction. DNase-resistant KSHV genomes were quantified by real-time qPCR. G iSLK.219 culture supernatants were transferred to naive HEK293 cells at 72 h post-doxycycline treatment. GFP + infected cells were measured at 48 h post-infection by fluorescent microscopy and (H) quantified by flow cytometry. P values are the result of two-tailed Student’s T tests unless otherwise specified. Error bars indicate the standard error of the mean of three independent biological replicates. Source data are provided as a source data file.
Fig. 3
Fig. 3. Increased BAF expression promotes KSHV reactivation.
iSLK.219 cells were transfected with either pCMV6 (EV) or pCMV6-BANF1-HA (BAF) expression plasmid for 48 h prior to the addition of 25 ng/mL doxycycline. A Cell lysates were collected at 96 h post-doxycycline treatment and analyzed by 2’3’-cGAMP ELISA. B Cell lysates were collected at 72 h post-doxycycline treatment and analyzed by western blotting with the indicated antibodies. C Cells were harvested and RNA was isolated at 72 h post-doxycycline treatment and subsequent RT-qPCR was performed to determine ISG mRNA expression levels. D Culture supernatant was harvested at 96 h post-doxycycline treatment and analyzed by IFNβ ELISA. E Fluorescent microscopy imaging of RFP and GFP signal was conducted at 96 h after doxycycline treatment and quantified (F) by plate reader. G Cells were harvested for RNA at 96 h post-doxycycline treatment and subsequent RT-qPCR was performed to quantify the expression of viral mRNA transcripts. H Cell lysates were prepared at 96 h post-doxycycline treatment and analyzed by western blotting with the indicated antibodies. I Culture supernatants were harvested at 96 h post-doxycycline treatment and DNase treated prior to DNA extraction. DNase-resistant KSHV genomes were quantified by real-time qPCR. J At 96 h post-doxycycline treatment, culture supernatants from iSLK.219 cells were used to infect naive HEK293 cells. GFP + infected cells were measured at 48 h post-transfer by fluorescent microscopy and (K) quantified by flow cytometry. L Cell lysates were prepared at 48 h post-siRNA transfection and analyzed by western blotting with the indicated antibody. P values are the result of two-tailed Student’s T tests unless otherwise specified. Error bars indicate the standard error of the mean of three independent biological replicates. Source data are provided as a source data file.
Fig. 4
Fig. 4. BAF promotes KSHV reactivation through a cGAS-dependent mechanism.
iSLK.219 cells were transfected with NTC, BANF1, cGAS, or BANF1 and cGAS targeting siRNA at a total siRNA concentration of 100 nM for 48 h prior to the addition of 25 ng/mL doxycycline. A Cell lysates were collected at 72 h post-doxycycline treatment and analyzed by 2’3’-cGAMP ELISA. B Cells were harvested for RNA at 48 h post-doxycycline treatment and subsequent RT-qPCR was performed to determine IFNB1 mRNA expression levels. C Culture supernatant was harvested at 72 h post-doxycycline treatment and analyzed by IFNβ ELISA. D Fluorescent microscopy imaging of RFP and GFP signal was conducted at 72 h after doxycycline treatment. E The fluorescence was quantified by a plate reader. F Cell lysates were prepared at 72 h post-doxycycline treatment and analyzed by western blotting with the indicated antibodies. G Culture supernatants were harvested 72 h post-doxycycline treatment and DNase treated prior to DNA extraction. DNase-resistant KSHV genomes were quantified by real-time qPCR. H At 72 h post-doxycycline treatment, culture supernatants from iSLK.219 cells were used to infect naive HEK293 cells. At 48 h post-transfer, GFP + infected cells were quantified by flow cytometry. I The cells were also analyzed by fluorescent microscopy. J Cell lysates were prepared at 48 h post-siRNA transfection and analyzed by western blotting with the indicated antibody. P values are the result of two-tailed Student’s T tests unless otherwise specified. Error bars indicate the standard error of the mean of three independent biological replicates. Source data are provided as a source data file.
Fig. 5
Fig. 5. BAF suppresses the antiviral state in uninfected, latently infected, and lytically infected cells.
A iSLK.219 cells were transfected with EV or BANF1 expression plasmids for 48 h prior to the addition of 100 μg/mL cycloheximide. Cell lysates were prepared at the indicated timepoints and analyzed by western blotting. B HeLa cells were transfected with EV or BANF1 expression plasmids for 48 h prior to treatment with 10 μM MG132 or DMSO control. Cell lysates were prepared 12 h post-treatment and analyzed by western blotting. C Naive SLK cells were infected with equivalent units of concentrated cell-free KSHV or PBS (mock). Cell lysates were prepared 6 h post-infection and analyzed by western blotting. D Naive SLK cells were transfected with BANF1 or NTC siRNA for 48 h prior to infection with equivalent units of concentrated cell-free KSHV. Lysates were prepared pre-infection and analyzed by western blot. Blots are representative of three independent biological replicates. E GFP + infected cells were analyzed at 48 h post-infection by fluorescent microscopy. F Cells were also quantified by flow cytometry. G Cells were harvested and RNA isolated at 48 h post-siRNA transfection and RT-qPCR was subsequently performed to quantify BANF1 mRNA transcripts. iSLK.219 cells were transfected with NTC siRNA or BANF1 targeting siRNA for 48 h prior to the addition of 25 ng/mL doxycycline. Cells from two biological replicates were harvested for RNA (H) at 0 h and (I) at 48 h post-doxycycline treatment and subjected to RNA-Seq analysis. Interferon-stimulated genes were identified using Interferome (http://www.interferome.org). Data were visualized with VolcaNoseR (https://huygens.science.uva.nl/VolcaNoseR/). Adjusted P values were calculated using the two-tailed Wald test with adjustments for multiple comparisons, and significantly enriched GO terms were determined by the one-tailed Fisher exact test with adjustments for multiple comparisons. P values are the result of two-tailed Student’s T tests unless otherwise specified. Error bars indicate the standard error of the mean of three independent biological replicates. Source data are provided as a source data file.
Fig. 6
Fig. 6. BAF facilitates EBV reactivation from latency in epithelial cells.
AGS-EBV cells were transfected with NTC or BANF1 targeting siRNA for 48 h prior to the addition of 5 ng/mL TPA. A Cell lysates were collected at 72 h post-TPA treatment and analyzed by 2’3’-cGAMP ELISA. B Cells were harvested and RNA was isolated at 48 h post-TPA treatment. RT-qPCR was subsequently performed to determine ISG mRNA expression levels. C Culture supernatant was harvested at 72 h post-TPA treatment and analyzed by IFNβ ELISA. D Cells were harvested and RNA was isolated at 72 h post-TPA treatment and RT-qPCR was performed to quantify viral mRNA transcripts. E Cell lysates were prepared at 72 h post-TPA treatment and analyzed by western blotting with the indicated antibodies. F Culture supernatants were harvested at 72 h post-TPA treatment and DNase treated prior to DNA extraction. DNase-resistant EBV genomes were quantified by real-time qPCR to assess viral load. G At 72 h post-TPA treatment, culture supernatants were used to infect naive HEK293 cells. Forty-eight h post infection, GFP + infected cells were analyzed by fluorescent microscopy. H Cells were also quantified by flow cytometry. I Cells were harvested for RNA at 48 h post-siRNA transfection and subsequent RT-qPCR was performed to quantify BANF1 mRNA transcripts. J Cell lysates were prepared at 48 h post-siRNA transfection and analyzed by western blotting with the indicated antibody. K Naive AGS cells were infected with equivalent units of concentrated cell-free EBV or PBS (mock). Cell lysates were prepared 6 h post-infection and analyzed by western blotting. P values are the result of two-tailed Student’s T tests unless otherwise specified. Error bars indicate the standard error of the mean of three independent biological replicates. Source data are provided as a source data file.

References

    1. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi’s sarcoma–associated herpesvirus-like DNA sequences in AIDS-related body-cavity–based lymphomas. N. Engl. J. Med. 1995;332:1186–1191. doi: 10.1056/NEJM199505043321802. - DOI - PubMed
    1. Chang Y, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266:1865–1869. doi: 10.1126/science.7997879. - DOI - PubMed
    1. Soulier J, et al. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood. 1995;86:1276–1280. doi: 10.1182/blood.V86.4.1276.bloodjournal8641276. - DOI - PubMed
    1. Farrell PJ. Epstein–Barr virus and cancer. Annu. Rev. Pathol. Mechanisms Dis. 2019;14:29–53. doi: 10.1146/annurev-pathmechdis-012418-013023. - DOI - PubMed
    1. Bjornevik K, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375:296–301. doi: 10.1126/science.abj8222. - DOI - PubMed

Publication types

Substances